September 15, 2021 -- Lab equipment supplier Waters has introduced the BioAccord system with Acquity Premier, a liquid chromatography-mass spectrometry (LC-MS) system designed to simplify the multiattribute monitoring of biotherapeutics.
BioAccord is a compact benchtop LC-MS system that combines the company's BioAccord platform with its Acquity RDA mass detector and MaxPeak high-performance surface technology.
The Waters BioAccord system with Acquity Premier is an easy-to-deploy-and-operate LC-MS system for performing multiattribute monitoring of biotherapeutics. In addition, it gives scientists faster access to mass spectrometry data. Image courtesy of Waters.
The system is designed to improve analyte recovery and assay-to-assay reproducibility, according to Waters. It eliminates analyte-to-metal surface interactions, which in turn can significantly enhance the recovery of hard-to-detect samples, the firm said.
Shipments are expected to begin in late September.
Copyright © 2021 scienceboard.net